Details
Title
Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapy
Author
Jung, Keunok 1 ; Deok-Han Ko 2 ; Jeong-Yun, Jang 2 ; Young Rong Kim 3 ; Heo, Jung Yeon 3 ; Yong-Sung, Kim 4
1 Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Republic of Korea
2 Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea
3 Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Republic of Korea
4 Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Republic of Korea; Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea
1 Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Republic of Korea
2 Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea
3 Department of Infectious Diseases, Ajou University School of Medicine, Suwon, Republic of Korea
4 Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Republic of Korea; Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea
Pages
173-177
Section
LETTERS TO THE EDITOR
Publication year
2024
Publication date
Jan 2024
e-ISSN
2523-3548
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2915665643
Copyright
© 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.